Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Jones

Showing results (481-490 of 490) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 490 results.
Schizophrenia Research|November 27, 2020
Pre-training inter-rater reliability of clinical instruments in an international psychosis research projectSteven Berendsen, Pim Kapitein, Frederike Schirmbeck, et al.
Schizophrenia Bulletin|July 19, 2023
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI StudyElisa Rodríguez-Toscano, Clara Alloza, David Fraguas, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2023
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control studyLucia Sideli, Monica Aas, Diego Quattrone, et al.
Schizophrenia Bulletin|February 9, 2022
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)Lucia Sideli, Adriano Schimmenti, Daniele La Barbera, et al.
Translational Psychiatry|August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI studyDiego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Molecular Psychiatry|October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohortsEmma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine|December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control studyGiulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine|December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studiesIsabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
The Lancet. Psychiatry|August 15, 2024
The Lancet Psychiatry Commission on youth mental healthPatrick D McGorry, Cristina Mei, Naeem Dalal, et al.
Molecular Psychiatry|January 8, 2021
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblingsEva Velthorst, Josephine Mollon, Robin M Murray, et al.
Pageof 49

Showing results (481-490 of 490) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 490 results.
Schizophrenia Research|November 27, 2020
Pre-training inter-rater reliability of clinical instruments in an international psychosis research projectSteven Berendsen, Pim Kapitein, Frederike Schirmbeck, et al.
Schizophrenia Bulletin|July 19, 2023
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI StudyElisa Rodríguez-Toscano, Clara Alloza, David Fraguas, et al.
Social Psychiatry and Psychiatric Epidemiology|June 19, 2023
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control studyLucia Sideli, Monica Aas, Diego Quattrone, et al.
Schizophrenia Bulletin|February 9, 2022
Childhood Maltreatment, Educational Attainment, and IQ: Findings From a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)Lucia Sideli, Adriano Schimmenti, Daniele La Barbera, et al.
Translational Psychiatry|August 11, 2021
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI studyDiego Quattrone, Ulrich Reininghaus, Alex L Richards, et al.
Molecular Psychiatry|October 15, 2024
Methylomic signature of current cannabis use in two first-episode psychosis cohortsEmma L Dempster, Chloe C Y Wong, Joe Burrage, et al.
Psychological Medicine|December 11, 2023
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control studyGiulia Trotta, Victoria Rodriguez, Diego Quattrone, et al.
Psychological Medicine|December 5, 2024
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studiesIsabelle Austin-Zimmerman, Edoardo Spinazzola, Diego Quattrone, et al.
The Lancet. Psychiatry|August 15, 2024
The Lancet Psychiatry Commission on youth mental healthPatrick D McGorry, Cristina Mei, Naeem Dalal, et al.
Molecular Psychiatry|January 8, 2021
Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblingsEva Velthorst, Josephine Mollon, Robin M Murray, et al.
Pageof 49